Showing results (2531-2540 of 2,626) with videos related to
Sort By:
Pageof 263
Virchows Archiv : an International Journal of Pathology|April 3, 2024
Scoring PD-L1 Expression in Urothelial Carcinoma: An International Multi-Institutional Study on Comparison of Manual and Artificial Intelligence Measurement Model (AIM-PD-L1) Pathology AssessmentsJosef Rüschoff, George Kumar, Sunil Badve, et al.The American Journal of Gastroenterology|January 13, 2006
Risk factors for post-ERCP pancreatitis: a prospective multicenter studyChi-Liang Cheng, Stuart Sherman, James L Watkins, et al.Science Immunology|March 10, 2023
Targeting the chromatin effector Pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancerYini Zhu, Yun Zhao, Jiling Wen, et al.Human Pathology|March 19, 2017
Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologistsSean R Williamson, Ramya Gadde, Kiril Trpkov, et al.Targeted Oncology|October 5, 2024
Single-Hit and Multi-hit PIK3CA Short Variant Genomic Alterations in Clinically Advanced Prostate Cancer: A Genomic Landscape StudyMichael F Basin, Carla M Miguel, Joseph M Jacob, et al.Histopathology|October 8, 2022
Low-grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivitySean R Williamson, Ondrej Hes, Kiril Trpkov, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 14, 2024
Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2Jessica M Posada, Evgeny Yakirevich, Ashish M Kamat, et al.Molecular Cell|September 8, 2015
Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome DegradationJian An, Shancheng Ren, Stephen J Murphy, et al.Nanomaterials (Basel, Switzerland)|July 25, 2025
Cu-Doping Induced Structural Transformation and Magnetocaloric Enhancement in CoCr2O4 NanoparticlesMing-Kang Ho, Yun-Tai Yu, Hsin-Hao Chiu, et al.European Urology Focus|December 18, 2025
Harnessing Artificial Intelligence for Risk Stratification and Outcome Prediction in Urologic Cancers: A Systematic ReviewNavid Roessler, Marcin Miszczyk, Keiichiro Miyajima, et al.Pageof 263